HUP0300878A2 - Vízben diszpergálható kapszulázott szterinek - Google Patents

Vízben diszpergálható kapszulázott szterinek

Info

Publication number
HUP0300878A2
HUP0300878A2 HU0300878A HUP0300878A HUP0300878A2 HU P0300878 A2 HUP0300878 A2 HU P0300878A2 HU 0300878 A HU0300878 A HU 0300878A HU P0300878 A HUP0300878 A HU P0300878A HU P0300878 A2 HUP0300878 A2 HU P0300878A2
Authority
HU
Hungary
Prior art keywords
water
sterol
micelles
dispersible
starch
Prior art date
Application number
HU0300878A
Other languages
English (en)
Inventor
Nicolas Auriou
Original Assignee
Novartis Nutrition Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Nutrition Ag. filed Critical Novartis Nutrition Ag.
Publication of HUP0300878A2 publication Critical patent/HUP0300878A2/hu
Publication of HUP0300878A3 publication Critical patent/HUP0300878A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Food Science & Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)

Abstract

A jelen találmány szerinti eljárásban egy vagy több szterinttartalmazó, vízben diszpergálható port állítanak elő. Az eljárásbanszterint és felületaktív anyagot tartalmazó micellákat készítenekvizes közegben, és ezeket a micellákat bevonják keményítő ésmódosított keményítő keverékével egy szárító lépésben. A szárítottport könnyen hozzá lehet adni vizes alapú ehető vagy ihatókészítményekhez, miáltal lehetővé válik korlátozott zsírtartalmúdiétával kapcsolatos, koleszterintcsökkentő szterin gyógyászatiadagolása. Ó
HU0300878A 2000-09-01 2001-08-30 Water-dispersible encapsulated sterols HUP0300878A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021498.1A GB0021498D0 (en) 2000-09-01 2000-09-01 New formulation
PCT/EP2001/010044 WO2002017892A2 (en) 2000-09-01 2001-08-30 Water-dispersible encapsulated sterols

Publications (2)

Publication Number Publication Date
HUP0300878A2 true HUP0300878A2 (hu) 2003-09-29
HUP0300878A3 HUP0300878A3 (en) 2008-03-28

Family

ID=9898673

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300878A HUP0300878A3 (en) 2000-09-01 2001-08-30 Water-dispersible encapsulated sterols

Country Status (17)

Country Link
EP (2) EP1315482B1 (hu)
JP (1) JP2004507492A (hu)
AT (1) ATE345783T1 (hu)
AU (1) AU2002213868A1 (hu)
BR (1) BR0113621A (hu)
CA (1) CA2419249A1 (hu)
CY (1) CY1106039T1 (hu)
DE (1) DE60124738T2 (hu)
DK (1) DK1315482T3 (hu)
ES (1) ES2277952T3 (hu)
GB (1) GB0021498D0 (hu)
HU (1) HUP0300878A3 (hu)
MX (1) MXPA03001831A (hu)
PL (1) PL359704A1 (hu)
PT (1) PT1315482E (hu)
WO (1) WO2002017892A2 (hu)
ZA (1) ZA200301097B (hu)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673383B2 (en) * 2001-03-26 2004-01-06 Unilever Patent Holdings Bv Method for improving the performance of a food product
US6773733B2 (en) 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
US20030003131A1 (en) * 2001-06-22 2003-01-02 Matthew Dyer Method for manufacture of free-flowing powder containing water-dispersible sterols
US20060147523A1 (en) 2002-10-16 2006-07-06 Alan Fergusson Composition for the regulation of the human immune system and the prevention and treatment of diseases thereof
DE10253111A1 (de) * 2002-11-13 2004-05-27 Basf Ag Pulverförmige Phytosterol-Formulierungen
WO2005018607A1 (ja) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. 溶解性を改善した医薬品製剤
CA2539734A1 (en) * 2003-09-22 2005-04-14 Degussa Health & Nutrition Americas, Inc. Incorporation of phytosterols into flavorings
EP1708579B1 (en) * 2004-01-30 2008-11-12 Unilever N.V. Particulate comprising phytosterols and food compositions comprising said creamer
US20050233002A1 (en) * 2004-04-15 2005-10-20 Trubiano Paolo C Encapsulation of oxygen sensitive agents
EP1602713B1 (en) * 2004-06-04 2006-10-11 The Procter & Gamble Company Encapsulated particles
US20060034934A1 (en) * 2004-08-13 2006-02-16 Deguise Matthew L Agglomeration of sterol particles
US20080305239A1 (en) * 2004-09-02 2008-12-11 Quest International Services, B.V. Heat Stable Flavouring Compositions
JP4915717B2 (ja) * 2004-09-09 2012-04-11 花王株式会社 肥満予防・改善剤
JPWO2006095798A1 (ja) * 2005-03-09 2008-08-14 サンスター株式会社 フィトステロールを含んだリポソームを含有する抗癌用経口組成物、該リポソームによる癌の予防又は治療
US8309156B2 (en) 2005-12-20 2012-11-13 Pharmachem Laboratories, Inc. Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high HLB emulsifiers
WO2007071038A2 (en) * 2005-12-20 2007-06-28 Forbes Medi-Tech Inc. Compositions comprising one or more phytosterols and/or phytostanols, or derivatives thereof, and high hlb emulsifiers
JP4989956B2 (ja) * 2006-12-11 2012-08-01 松谷化学工業株式会社 粉末化植物ステロールエステル製剤、その製造方法及びこれを含む飲食品
EP2217094A1 (en) * 2007-12-05 2010-08-18 DSM IP Assets B.V. Pulverous formulation of a fat-soluble active ingredient
US20100272861A1 (en) * 2007-12-05 2010-10-28 Thomas Lindemann Pulverous formulation of a fat-soluble active ingredient
EP2067410A1 (en) * 2007-12-07 2009-06-10 Cognis IP Management GmbH Water-dispersable sterol containing dispersion
JPWO2010093020A1 (ja) * 2009-02-13 2012-08-16 日新化成株式会社 硬カプセル
ES2374780A1 (es) * 2009-12-30 2012-02-22 José Javier Villa Cervera Procedimiento de fabricación de agua de beber, agua mineral, agua medicinal o similar, caracterizada porque incluye esteroles vegetales-fitoesteroles. la bebida contiene de 0.1 a 3 g litro de esteroles vegetales.
CN103459008B (zh) 2010-12-28 2015-08-19 荷兰联合利华有限公司 乳化的方法
US20120282368A1 (en) * 2011-05-03 2012-11-08 Brandeis University Amphiphilic sterol/fat-based particles
JP6092579B2 (ja) * 2012-11-07 2017-03-08 理研ビタミン株式会社 粉末状植物ステロール組成物およびその製造方法
CN104822276A (zh) * 2012-11-07 2015-08-05 理研维他命股份有限公司 粉末状植物甾醇组合物及其制造方法
JP6092580B2 (ja) * 2012-11-07 2017-03-08 理研ビタミン株式会社 粉末状植物ステロール組成物およびその製造方法
US11779019B2 (en) 2017-08-07 2023-10-10 Elicit Plant Composition made from polyol(s) and sterol(s) for use in the agricultural field
FR3069757B1 (fr) * 2017-08-07 2021-07-23 Innovi Production Composition a base de sterols
US20220312762A1 (en) * 2019-09-06 2022-10-06 The Texas A&M University System Use of encapsulated sterols to modify growth of crops, control, agricultural pests and as non-toxic pre-emergent herbicides
CN115969036B (zh) * 2023-01-10 2024-05-07 丰益油脂科技有限公司 植物甾醇颗粒物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
JPS62186936A (ja) 1986-02-13 1987-08-15 Asahi Denka Kogyo Kk ステリン乳化乃至可溶化組成物
US5405615A (en) 1991-09-17 1995-04-11 Micro Vesicular Systems, Inc. Sucrose distearate lipid vesicles
WO1999018977A1 (en) 1997-10-16 1999-04-22 Medical Isotopes Inc. Readily absorbable phytosterol glycosides to treat hypercholesterolemia
IN185730B (hu) * 1998-02-19 2001-04-14 Mcneil Ppc Inc

Also Published As

Publication number Publication date
WO2002017892A3 (en) 2002-05-16
BR0113621A (pt) 2003-07-22
EP1749520A1 (en) 2007-02-07
GB0021498D0 (en) 2000-10-18
ES2277952T3 (es) 2007-08-01
PL359704A1 (en) 2004-09-06
MXPA03001831A (es) 2003-06-04
PT1315482E (pt) 2007-02-28
ATE345783T1 (de) 2006-12-15
HUP0300878A3 (en) 2008-03-28
CA2419249A1 (en) 2002-03-07
CY1106039T1 (el) 2011-04-06
DE60124738D1 (de) 2007-01-04
JP2004507492A (ja) 2004-03-11
WO2002017892A2 (en) 2002-03-07
EP1315482B1 (en) 2006-11-22
DE60124738T2 (de) 2007-09-13
AU2002213868A1 (en) 2002-03-13
DK1315482T3 (da) 2007-04-02
ZA200301097B (en) 2004-04-21
EP1315482A2 (en) 2003-06-04

Similar Documents

Publication Publication Date Title
HUP0300878A2 (hu) Vízben diszpergálható kapszulázott szterinek
WO2002008190A3 (de) Neue heteroaryl-derivate und deren verwendung als antitumormittel
ZA200203152B (en) Soy milk compositions and methods of preparation.
NO20033283L (no) Kombinasjon av probiotika
HK1067573A1 (en) Perfuming or flavouring microcapsules comprising afireproofing agent
MY133392A (en) Novel substituted pyrazole derivatives
AU2002223647A1 (en) Aryl-substituted indirubin derivatives, the production thereof and use of the same
HUP0300527A3 (en) Pyrrolopyrimidinone derivatives, process of preparation and use
ATE278329T1 (de) Aromatisiertes lösliches aufhellerpulver
HUP0303750A2 (hu) Egy ciklooxigenáz-2 enzimet gátló hatóanyagot tartalmazó, újrafeloldható, parenterális gyógyszerkészítmény
IL204947A0 (en) Phenylacetamido-thiazole derivatives, process for their preparation and their use in the manufacture of medicaments, pharmaceutical compositions and kits comprising them
HUP0401592A2 (hu) Modafinilvegyület és ciklodextrin keverékek, eljárás az előállításukra és ezeket tartalmazó készítmények
HUP0105364A2 (hu) Spontán diszpergálódó N-benzoil sztaurosporint tartalmazó gyógyszerkészítmények és alkalmazásuk
IL154034A0 (en) Indole, azaindole and indazole derivatives, processes for their preparation, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments for use in the production of an antiangiogenic and/or vascular permeability reducing effect in warm-blooded animals
IL161995A (en) Purified strain of lactic acid bacterium and uses thereof in the preparation of edible compositions, drugs and veterinary products
WO2003030899A3 (en) Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders
EP1166645A3 (en) Agglomerated starch- and maltodextrin-based product for food preparations
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
IL157065A0 (en) 2h-1-benzopyran derivatives, processes for their preparation and pharmaceutical compositions thereof
HUP0203740A2 (en) Food product and process
AU6866500A (en) Chromone derivatives, process for the preparation of the same and uses thereof
WO2004010972A3 (en) Pellicle-resistant gelatin capsule
DE50009804D1 (de) Vernetzerfreie zubereitungen
AU2001278804A1 (en) 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
AU2002316617A1 (en) Anticancer polypeptide-metal complexes and compositions, methods of making, and methods of using same

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees
GB9A Succession in title

Owner name: FORBES MEDI-TECH INC., CA

Free format text: FORMER OWNER(S): NOVARTIS NUTRITION AG., CH

NF4A Restoration of patent protection
FD9A Lapse of provisional protection due to non-payment of fees